A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Potential Anti-tumor Effects of SSGJ-705 in Patients With Advanced or Metastatic HER2-expressing Solid Tumors
Clinical trial NCT05145179 · UNKNOWN
Trial details
- NCT number
- NCT05145179
- Sponsor
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2023-12-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.